3 recruiting, 2 completed, 1 active not recruiting, 1 not yet recruiting. 8 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 8 | Recruiting 3, Completed 2, Active not recruiting 1, Not yet recruiting 1, Unknown 1 |
| Phase 2 | 4 | Completed 2, Active not recruiting 1, Recruiting 1 |
Follow Combat Disorders: new trials by email Literature Review of Combat Disorders trials Research Report on Combat Disorders
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Women Who Are Victims of Violence: Treatment of PTSD Through Reactivation of Traumatic Memories Using Propranolol Propranolol, Psychotherapy - Post-Traumatic Stress Disorder, PTSD | Phase 3 | Not yet recruiting | University Hospital, Toulouse | 70 | 2026-12-01 | 2026-11-06 |
| Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder COMP360 psilocybin - PTSD - Post Traumatic Stress Disorder, PTSD | Phase 2 / Phase 3 | Recruiting | COMPASS Pathways | 300 | 2026-09-14 | 2026-11-05 |
| REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool Senseye Diagnostic Tool (DT), Clinician Administered PTSD Scale for DSM-5, Revised Version - PTSD - Post Traumatic Stress Disorder | Phase 3 | Recruiting | Senseye, Inc. | 1900 | 2026-02-23 | 2026-04-29 |
| Software as a Medical Device for the Treatment of Patients With PTSD Software as a Medical Device - Post-Traumatic Stress Disorder, PTSD | Phase 2 / Phase 3 | Active not recruiting | Otsuka Medical Devices Co., Ltd. Japan | 52 | 2024-09-01 | 2026-10-19 |
| Examining 3,4-methylenedioxymethamphetamine (MDMA) Effects on Psychological, Relational and Hyperarousal-Related Neural Reactivity Mechanisms in Veterans With PTSD and Moral Injury MDMA-AT, SEA-IT - PTSD, Post Traumatic Stress Disorder, Moral Injury | Phase 3 | Recruiting | Herzog Hospital | 60 | 2024-05-20 | 2026-11-03 |
| Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration Expressive Writing, Control Writing - Posttraumatic Stress Disorder | Phase 2 / Phase 3 | Completed | Minneapolis Veterans Affairs Medical Center | 1292 | 2011-06-01 | 2015-09-23 |
| A Head-to-head Comparison of Virtual Reality Treatment for Post Traumatic Stress Disorder Virtual Reality Exposure Therapy - Dynamic, Augmented Exposure Therapy - Post Traumatic Stress Disorder | Phase 3 | Unknown | United States Naval Medical Center, San Diego | 150 | 2009-09-01 | 2014-06-30 |
| Exposure Therapy for Chronic PTSD: Efficacy and Mechanisms Prolonged Exposure therapy for PTSD, Present centered therapy for PTSD - Combat Disorders, Posttraumatic Stress Disorder | Phase 2 / Phase 3 | Completed | VA Office of Research and Development | 36 | 2008-01-01 | 2019-02-15 |
Stress Disorders, Post-Traumatic (7) · Anxiety Disorders (2) · Depression (2) · Wounds and Injuries (2) · Depressive Disorder, Major (1)
Mental Disorders (8) · Stress Disorders, Traumatic (8) · Trauma and Stressor Related Disorders (8) · Behavior (2) · Behavioral Symptoms (2) · Depressive Disorder (1) · Mood Disorders (1)
Propranolol (1) · Psychotherapy (1) · beta-Aminoethyl Isothiourea (1)
COMPASS Pathways (1) · Herzog Hospital (1) · Minneapolis Veterans Affairs Medical Center (1) · Otsuka Medical Devices Co., Ltd. Japan (1) · Senseye, Inc. (1) · United States Naval Medical Center, San Diego (1) · University Hospital, Toulouse (1) · VA Office of Research and Development (1)
United States (5) · Australia (1) · Canada (1) · France (1) · Israel (1) · Japan (1)
Anna Harwood-Gross, PhD (1) · Nina A Sayer, PhD (1) · Philippe Birmes, PHD (1) · Pinhas Danon, Prof (1) · Robert N McLay, MD/PhD (1) · Sheila Rauch, PhD (1)
PMID 23696427, PMID 24913102, PMID 28102979, PMID 35950709
2025 (1)